| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Farber Jeffrey |
Director |
– • • |
2022-03-17 |
4 |
B |
$0.81 |
$16,200 |
D/D |
20,000 |
2,152,454 |
3.92 |
-30% |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2022-02-15 |
4 |
B |
$0.81 |
$9,720 |
D/D |
12,000 |
175,453 |
2.74 |
-34% |
|
| Chapman John C |
Director |
– • – |
2022-02-11 |
4 |
B |
$0.80 |
$10,000 |
D/D |
12,500 |
154,324 |
2.39 |
-26% |
|
| Abt John |
Chief Quality and Operations |
• – – |
2022-02-10 |
4 |
B |
$0.90 |
$4,500 |
D/D |
5,000 |
128,815 |
2.66 |
-35% |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2022-02-10 |
4 |
AB |
$0.93 |
$46,500 |
D/D |
50,000 |
634,270 |
|
-35% |
|
| Farber Jeffrey |
Director |
– • • |
2022-02-09 |
4 |
B |
$0.92 |
$9,200 |
D/D |
10,000 |
2,132,454 |
3.84 |
-31% |
|
| Lepore Patrick G |
Director |
– • – |
2022-02-08 |
4 |
B |
$0.88 |
$44,000 |
D/D |
50,000 |
437,145 |
2.39 |
-32% |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2021-12-31 |
4 |
A |
$1.38 |
$2,349 |
D/D |
1,702 |
163,453 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2021-12-31 |
4 |
A |
$1.38 |
$1 |
D/D |
1 |
123,815 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2021-12-14 |
4 |
B |
$1.81 |
$8,869 |
D/D |
4,900 |
157,494 |
2.74 |
-65% |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2021-12-13 |
4 |
AB |
$1.99 |
$39,800 |
D/D |
20,000 |
584,270 |
|
-64% |
|
| Ehlinger Robert |
Former VP and CIO |
– – – |
2021-12-03 |
4 |
D |
$1.78 |
$66,453 |
D/D |
(37,333) |
105,491 |
|
- |
|
| Ehlinger Robert |
Former VP and CIO |
– – – |
2021-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
57,992 |
142,824 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2021-11-29 |
4 |
B |
$1.71 |
$85,500 |
D/D |
50,000 |
387,145 |
2.39 |
-50% |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2021-09-30 |
4 |
A |
$2.55 |
$1,958 |
D/D |
768 |
161,751 |
|
- |
|
| Rewolinski Melissa |
Director |
– • – |
2021-09-09 |
4 |
S |
$3.18 |
$80,581 |
D/D |
(25,340) |
62,100 |
|
52% |
|
| Lepore Patrick G |
Director |
– • – |
2021-09-08 |
4 |
B |
$3.31 |
$66,200 |
D/D |
20,000 |
337,145 |
2.39 |
-54% |
|
| Abt John |
Chief Quality and Operations |
• – – |
2021-09-07 |
4 |
D |
$3.40 |
$3,230 |
D/D |
(950) |
123,814 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2021-09-07 |
4 |
D |
$3.40 |
$1,615 |
D/D |
(475) |
141,593 |
|
- |
|
| Rewolinski Melissa |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,819 |
87,440 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,819 |
117,220 |
|
- |
|
| Chapman John C |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,819 |
141,824 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,819 |
317,145 |
|
- |
|
| Farber Jeffrey |
Director |
– • • |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,819 |
2,112,454 |
|
- |
|
| Drabik David A |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,819 |
108,332 |
|
- |
|
762 Records found
|
|
Page 2 of 31 |
|
|
